Investors are on the edge of their collective seats, hoping that Molina Healthcare
What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on Molina Healthcare, with seven out of 12 analysts rating it a hold. Analysts like Molina Healthcare better than competitor WellCare Health Plans overall. Two out of 12 analysts rate WellCare Health Plans a buy compared to four out of 12 for Molina Healthcare. Analysts still rate the stock a hold, but they are a bit more wary about it compared to three months ago.
- Revenue forecasts: On average, analysts predict $1.21 billion in revenue this quarter. That would represent a rise of 12% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.39 per share. Estimates range from $0.35 to $0.43.
What our community says:
CAPS All-Stars are strongly supporting the stock, with 94% assigning it an outperform rating. The community at large backs the All-Stars, with 91.5% awarding it a rating of outperform. Fools are keen on Molina Healthcare, though the message boards have been quiet lately, with only two posts in the past 30 days. Even with a robust four out of five stars, Molina Healthcare's CAPS rating falls a little short of the community's upbeat outlook.
Molina Healthcare's income has fallen year over year by an average of 87% over the past five quarters.
One final thing: If you want to keep tabs on Molina Healthcare's movements, and for more analysis on the company, make sure you add it to your Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks.